veterans health administration
play

Veterans Health Administration Taeko Minegishi, MS - PowerPoint PPT Presentation

Opioid Tapering at the Veterans Health Administration Taeko Minegishi, MS Taeko.Minegishi@va.gov VETERANS HEALTH ADMINISTRATION Collaborators & Disclaimers Office of Mental Health and Suicide Prevention Office VA Pharmacy Benefits


  1. Opioid Tapering at the Veterans Health Administration Taeko Minegishi, MS Taeko.Minegishi@va.gov VETERANS HEALTH ADMINISTRATION

  2. Collaborators & Disclaimers Office of Mental Health and Suicide Prevention Office VA Pharmacy Benefits Management Partners Evidence-based Policy Resource Center • Melissa Garrido, PhD • Steven Pizer, PhD • Austin Frakt, PhD The contents of this presentation do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. VETERANS HEALTH ADMINISTRATION 2

  3. Opioid Tapering Assist Primary Care providers in: - determining if an opioid taper is necessary - performing the taper - providing follow-up and support during the taper VETERANS HEALTH ADMINISTRATION 3

  4. Objective How prevalent is long-term high-dose opioid patients in VHA? - >90 days continuous and >90 MEDD Do we see opioid tapering in the VHA? Are there unintended consequences of opioid tapering? - serious adverse events and overdose death VETERANS HEALTH ADMINISTRATION 4

  5. Why VHA? High risk vulnerable population - Mental health - Chronic pain Data advantage - National Healthcare System (128 VHA medical stations) - Long-term prescription data for patients who use any of the VHA medical centers - Match hospital utilization and patient diagnosis VETERANS HEALTH ADMINISTRATION 5

  6. Cohort Definitions FY13 (baseline) : N= 1.4 million patients Any opioid prescription N = 53,799 At least 90 days of prescription and > 90 MEDD N = 43,539 Exclude if any inpatient admission, metastatic cancer, hospice, or palliative care N = 35,138 At least one 90 days continuous prescription Followed their opioid prescriptions through FY16 VETERANS HEALTH ADMINISTRATION 6

  7. Prevalence of Long-term High-dose Opioid Patients VETERANS HEALTH ADMINISTRATION 7

  8. Length of Opioid Prescription VETERANS HEALTH ADMINISTRATION 8

  9. Opioid Prescription Trends • To zero • To zero and back • Always decreasing • Always increasing • Others To zero and Always Always N To zero back decreasing Increasing Others 35,138 8,727 703 6,288 1,386 18,034 25% 2% 18% 4% 51% VETERANS HEALTH ADMINISTRATION 9

  10. Always Decreasing • To zero • To zero and back • Always decreasing • Always increasing • Others To zero and Always Always N To zero back decreasing Increasing Others 35,138 8,727 703 6,288 1,386 18,034 25% 2% 18% 4% 51% VETERANS HEALTH ADMINISTRATION 10

  11. Always Decreasing: Annual MEDD Trend VETERANS HEALTH ADMINISTRATION 11

  12. Always Decreasing: % Decrease per year ~ 22% per year Some evidence that higher MEDD patients reduce faster? VETERANS HEALTH ADMINISTRATION 12

  13. Geographic Variation in Fast Taper Fast tapering could be dangerous for high dose patients Tapering of >22% per year is common VETERANS HEALTH ADMINISTRATION 13

  14. To zero • To zero • To zero and back • Always decreasing • Always increasing • Others To zero and Always Always N To zero back decreasing Increasing Others 35,138 8,727 703 6,288 1,386 18,034 25% 2% 18% 4% 51% VETERANS HEALTH ADMINISTRATION 14

  15. To Zero: Deceased • 47% of patients were reported deceased (cause of death unknown at this point) 30% died within 6 months of their last prescription date VETERANS HEALTH ADMINISTRATION 15

  16. Main Findings How prevalent is long-term high-dose opioid patients in VHA? • On average 2.8% of patients are long-term high-dose opioid patients in each VHA medical centers Do we see opioid tapering in the VHA? • 18% of patients MEDD consistently decreased over 4 years – Some evidence that higher MEDD patients reduce faster – Tapering >22% per year is common Are there unintended consequences of opioid tapering? • 25% of patients tapered to zero and ~50% of patients deceased during/post prescription periods • Causal direction is unknown VETERANS HEALTH ADMINISTRATION 16

  17. Next Steps • Analysis with shorter time intervals: quarterly and monthly • Cause of death • Link with outcomes: overdose death and serious adverse events • Explore the “others” group (>50%) VETERANS HEALTH ADMINISTRATION 17

  18. Opioid Tapering at the Veterans Health Administration Taeko Minegishi, MS Taeko.Minegishi@va.gov VETERANS HEALTH ADMINISTRATION

Recommend


More recommend